Michael Lane - Aug 3, 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane
Stock symbol
IDXX
Transactions as of
Aug 3, 2021
Transactions value $
-$4,038,633
Form type
4
Date filed
8/5/2021, 05:01 PM
Next filing
Feb 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $99.9K +1.47K +40.36% $67.85* 5.12K Aug 3, 2021 Direct F1
transaction IDXX Common Stock Options Exercise $74K +1.09K +21.31% $67.85* 6.21K Aug 3, 2021 Direct
transaction IDXX Common Stock Options Exercise $628K +4.44K +71.43% $141.60 10.6K Aug 3, 2021 Direct
transaction IDXX Common Stock Sale -$1.69M -2.45K -23.02% $690.20 8.2K Aug 3, 2021 Direct F2
transaction IDXX Common Stock Sale -$173K -250 -3.05% $691.54 7.95K Aug 3, 2021 Direct F3
transaction IDXX Common Stock Sale -$252K -363 -4.57% $692.85 7.58K Aug 3, 2021 Direct F4
transaction IDXX Common Stock Sale -$1M -1.45K -19.08% $693.73 6.14K Aug 3, 2021 Direct F5
transaction IDXX Common Stock Sale -$636K -916 -14.93% $694.79 5.22K Aug 3, 2021 Direct F6
transaction IDXX Common Stock Sale -$69.6K -100 -1.92% $695.50 5.12K Aug 3, 2021 Direct
transaction IDXX Common Stock Sale -$65.3K -95 -1.86% $687.47 5.02K Aug 3, 2021 Direct F7
transaction IDXX Common Stock Sale -$169K -245 -4.88% $688.54 4.78K Aug 3, 2021 Direct F8
transaction IDXX Common Stock Sale -$169K -245 -5.13% $689.43 4.53K Aug 3, 2021 Direct F9
transaction IDXX Common Stock Sale -$20.7K -30 -0.66% $690.33 4.5K Aug 3, 2021 Direct F10
transaction IDXX Common Stock Sale -$69.1K -100 -2.22% $691.35 4.4K Aug 3, 2021 Direct F11
transaction IDXX Common Stock Sale -$41.6K -60 -1.36% $692.65 4.34K Aug 3, 2021 Direct F12
transaction IDXX Common Stock Sale -$57.8K -84 -1.92% $687.59 4.28K Aug 3, 2021 Direct F13
transaction IDXX Common Stock Sale -$206K -299 -7.02% $688.51 3.96K Aug 3, 2021 Direct F14
transaction IDXX Common Stock Sale -$105K -153 -3.86% $689.51 3.81K Aug 3, 2021 Direct F15
transaction IDXX Common Stock Sale -$69.1K -100 -2.63% $691.19 3.71K Aug 3, 2021 Direct F16
transaction IDXX Common Stock Sale -$41.6K -60 -1.62% $692.56 3.65K Aug 3, 2021 Direct F17
transaction IDXX Common Stock Sale -$693 -1 -0.03% $693.17 3.65K Aug 3, 2021 Direct
holding IDXX Common Stock 592 Aug 3, 2021 by spouse F18

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -1.47K -76.11% 462 Aug 3, 2021 Common Stock 1.47K $67.85 Direct F19, F22
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -1.09K -100% 0 Aug 3, 2021 Common Stock 1.09K $67.85 Direct F20, F22
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -4.44K -74.58% 1.51K Aug 3, 2021 Common Stock 4.44K $141.60 Direct F21, F22
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 23.2845 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.
F2 Represents the weighted average sales price of the shares sold ranging from a low of $690.00 to a high of $690.965 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3 Represents the weighted average sales price of the shares sold ranging from a low of $691.085 to a high of $692.08 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4 Represents the weighted average sales price of the shares sold ranging from a low of $692.33 to a high of $693.26 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5 Represents the weighted average sales price of the shares sold ranging from a low of $693.38 to a high of $694.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6 Represents the weighted average sales price of the shares sold ranging from a low of $694.49 to a high of $695.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F7 Represents the weighted average sales price of the shares sold ranging from a low of $686.91 to a high of $687.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F8 Represents the weighted average sales price of the shares sold ranging from a low of $688.07 to a high of $688.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F9 Represents the weighted average sales price of the shares sold ranging from a low of $689.14 to a high of $690 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F10 Represents the weighted average sales price of the shares sold ranging from a low of $690.17 to a high of $690.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F11 Represents the weighted average sales price of the shares sold ranging from a low of $691.19 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F12 Represents the weighted average sales price of the shares sold ranging from a low of $692.27 to a high of $692.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F13 Represents the weighted average sales price of the shares sold ranging from a low of $687.05 to a high of $687.83 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F14 Represents the weighted average sales price of the shares sold ranging from a low of $688.09 to a high of $688.97 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F15 Represents the weighted average sales price of the shares sold ranging from a low of $689.25 to a high of $690.18 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F16 Represents the weighted average sales price of the shares sold ranging from a low of $690.45 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F17 Represents the weighted average sales price of the shares sold ranging from a low of $692.125 to a high of $692.85 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F18 Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
F19 Grant of option to buy 2,072 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017.
F20 Grant of option to buy 10,749 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017.
F21 Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018.
F22 Not applicable.